Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $3.17 to $3.46
• 50-Day Range: $2.90 to $5.37
• 52-Week Range: $2.34 to $8.79
• Volume: 52,850 shs
• Average Volume: 185,021 shs
• Market Capitalization: $115.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of the year. Since then, AVR stock has decreased by 42.7% and is now trading at $3.20.

How were Anteris Technologies Global's earnings last quarter?

Anteris Technologies Global Corp. (NASDAQ:AVR) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an initial public offering on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

When did the company's lock-up period expire?

Anteris Technologies Global's lock-up period expired on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its IPO on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/29/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Anteris Technologies Global: $16.50
• High Price Target: $22.00
• Low Price Target: $9.00
• Potential Upside/Downside: +415.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.67
• Quick Ratio: 3.65

Sales & Book Value

• Annual Sales: $2.70 million
• Price / Sales: 42.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.74 per share
• Price / Book: 1.84

Miscellaneous

• Outstanding Shares: 36,060,000
• Free Float: N/A
• Market Cap: $115.39 million
• Optionable: N/A
• Beta: N/A